in partnership with
DRC Logo

March 13, 2019

Treating AMD

Researchers at the Retina Foundation are working diligently to find treatments for patients diagnosed with dry age-related macular degeneration (AMD). Learn more about the clinical trials we are currently enrolling for.

Read More

Researching AMD

Our researchers are working to develop a drug delivery device for patients with AMD. It is a small Polymer device that slowly releases therapeutic drugs as needed over a period of weeks, months or years as prescribed by your physician.

Read More

Understanding AMD

Age-related macular degeneration can be detected in a routine eye exam. One of the most common early signs of macular degeneration is the presence of drusen — tiny yellow deposits under the retina — or pigment clumping. Research is looking at the role drusen degeneration plays in AMD.

Read More

February 25, 2016

Retina Foundation to Conduct First Optogenetics Gene Therapy Clinical Trial

First-in-human trial of a new gene therapy that seeks to restore sight for patients affected with retinitis pigmentosa (Dallas, Texas …

Read More
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.

Please check all that apply:

How did you learn about the
Retina Foundation?

  • Please check all that apply:
  • This field is for validation purposes and should be left unchanged.
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form